Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalidomide”

381 trials

Showing 20 of 381 results

Large-scale testing (Phase 3)UnknownNCT02387086
What this trial is testing

Gefitinib Combined With Thalidomide to Treat NSCLC

Who this might be right for
NSCLC
Bai Jun 380
Post-approval studies (Phase 4)UnknownNCT01640639
What this trial is testing

THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure

Who this might be right for
Congestive Heart Failure
University of Roma La Sapienza 100
Large-scale testing (Phase 3)WithdrawnNCT00787436
What this trial is testing

Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

Who this might be right for
Gastrointestinal HemorrhagePortal Hypertension
The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT00083902
What this trial is testing

Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 190
Testing effectiveness (Phase 2)UnknownNCT04680195
What this trial is testing

Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding

Who this might be right for
Chronic Radiation Proctitis
Sixth Affiliated Hospital, Sun Yat-sen University 62
Testing effectiveness (Phase 2)UnknownNCT00027664
What this trial is testing

Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Cancer Research UK 90
Testing effectiveness (Phase 2)UnknownNCT02879526
What this trial is testing

Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma

Who this might be right for
Relapse/Refratory Peripheral T Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 45
Testing effectiveness (Phase 2)Study completedNCT00540007
What this trial is testing

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Washington University School of Medicine 80
Testing effectiveness (Phase 2)UnknownNCT04382300
What this trial is testing

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Who this might be right for
Non-small-cell Lung Cancer
Shanghai Chest Hospital 39
Large-scale testing (Phase 3)UnknownNCT03016000
What this trial is testing

Thalidomide Maintenance Treatment in DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Nanfang Hospital, Southern Medical University 226
Testing effectiveness (Phase 2)UnknownNCT03043105
What this trial is testing

TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial

Who this might be right for
Multicentric Castleman Disease
Peking Union Medical College Hospital 25
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00373646
What this trial is testing

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

Who this might be right for
MALT Lymphoma
Medical University of Vienna 8
Large-scale testing (Phase 3)Active Not RecruitingNCT00602641
What this trial is testing

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 306
Early research (Phase 1)Study completedNCT00251797
What this trial is testing

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Who this might be right for
Brain and Nervous SystemCancer
University of New Mexico 10
Testing effectiveness (Phase 2)Ended earlyNCT00953615
What this trial is testing

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing Cholangitis
Mayo Clinic 1
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Testing effectiveness (Phase 2)Study completedNCT00891618
What this trial is testing

Acupuncture for Chemo-Induced Peripheral Neuropathy

Who this might be right for
LymphomaMyelomaPeripheral Neuropathy
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)UnknownNCT00958854
What this trial is testing

Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 37
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation